|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-4.35/-2.67
|
企業價值
469.17M
|
資產負債 |
每股賬面淨值
4.04
|
現金流量 |
現金流量率
--
|
損益表 |
收益
100.39M
|
每股收益
2.86
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/21 10:11 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer. |